Ratings
0
Nobody has rated this yet. Be the first!
Influences rating
Influences rating
Subject of
23
Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer
A review of 65 years of human adenovirus seroprevalence
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility--Illinois, 2005.
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
Suppression of RNA interference by adenovirus virus-associated RNA.
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
